Restor3d will acquire all of the outstanding stock shares of Conformis in cash, paying a 96 percent premium per share on the June 22 closing price, according to a press release.
Conformis’ board of directors unanimously approved the transaction, saying that it is in the best interests of company stockholders. The transaction is expected to close at the end of the third quarter, subject to customary closing conditions.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
